Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Cited by CrossRef (48)

  1. C. Austin Zamarripa, Shelley R. Edwards, Hina N. Qureshi, John N. Yi, Bruce E. Blough, Kevin B. Freeman. The G-protein biased mu-opioid agonist, TRV130, produces reinforcing and antinociceptive effects that are comparable to oxycodone in rats. Drug and Alcohol Dependence 2018;192:158
    https://doi.org/10.1016/j.drugalcdep.2018.08.002
  2. Alena Randáková, Dominik Nelic, Dana Ungerová, Peter Nwokoye, Qiwen Su, Vladimír Doležal, Esam E. El‐Fakahany, John Boulos, Jan Jakubík. Novel M 2 ‐selective, G i ‐biased agonists of muscarinic acetylcholine receptors . Br J Pharmacol 2020;177:2073
    https://doi.org/10.1111/bph.14970
  3. Morten Adler Hedegaard, Birgitte Holst. The Complex Signaling Pathways of the Ghrelin Receptor. 2020;161
    https://doi.org/10.1210/endocr/bqaa020
  4. Steffen Hahnel, Nic Wheeler, Zhigang Lu, Arporn Wangwiwatsin, Paul McVeigh, Aaron Maule, Matthew Berriman, Timothy Day, Paula Ribeiro, Christoph G. Grevelding, James B. Lok. Tissue-specific transcriptome analyses provide new insights into GPCR signalling in adult Schistosoma mansoni. PLoS Pathog 2018;14:e1006718
    https://doi.org/10.1371/journal.ppat.1006718
  5. Walter Gottlieb Land. Damage-Associated Molecular Patterns in Human Diseases. 2018.
    https://doi.org/10.1007/978-3-030-53868-2_2
  6. Nanshan Song, Yinquan Fang, Xiyang Sun, Qingling Jiang, Chenghuan Song, Miaomiao Chen, Jianhua Ding, Ming Lu, Gang Hu. Salmeterol, agonist of β2-aderenergic receptor, prevents systemic inflammation via inhibiting NLRP3 inflammasome. Biochemical Pharmacology 2018;150:245
    https://doi.org/10.1016/j.bcp.2018.02.009
  7. Paula Santos-Otte, Hanne Leysen, Jaana van Gastel, Jhana O. Hendrickx, Bronwen Martin, Stuart Maudsley. G Protein-Coupled Receptor Systems and Their Role in Cellular Senescence. Computational and Structural Biotechnology Journal 2019;17:1265
    https://doi.org/10.1016/j.csbj.2019.08.005
  8. Thomas M. Tzschentke, Kris Rutten. Mu-opioid peptide (MOP) and nociceptin/orphanin FQ peptide (NOP) receptor activation both contribute to the discriminative stimulus properties of cebranopadol in the rat. Neuropharmacology 2018;129:100
    https://doi.org/10.1016/j.neuropharm.2017.11.026
  9. Qing Song, Qing Ji, Qi Li. The role and mechanism of β‑arrestins in cancer invasion and metastasis (Review). Int J Mol Med 2017
    https://doi.org/10.3892/ijmm.2017.3288
  10. Min Woo Kim, Wenjing Wang, Mateo I Sanchez, Robert Coukos, Mark von Zastrow, Alice Y Ting. Time-gated detection of protein-protein interactions with transcriptional readout. 2017;6
    https://doi.org/10.7554/eLife.30233
  11. Dongyun Zhang, Anthony P. Heaney. Prolactin Disorders. 2017.
    https://doi.org/10.1007/978-3-030-11836-5_13
  12. Justin LaVigne, Attila Keresztes, Daniel Chiem, John M. Streicher. The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor. Pharmacol. Rep 2020;72:465
    https://doi.org/10.1007/s43440-020-00061-x
  13. Mohammad M. Ahmadzai, David Broadbent, Christopher Occhiuto, Canchai Yang, Rupali Das, Hariharan Subramanian. G Protein-Coupled Receptors in Immune Response and Regulation. 2020.
    https://doi.org/10.1016/bs.ai.2017.05.004
  14. Katherine E. Squires, Carolina Montañez-Miranda, Rushika R. Pandya, Matthew P. Torres, John R. Hepler, Alan V. Smrcka. Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease. Pharmacol Rev 2018;70:446
    https://doi.org/10.1124/pr.117.015354
  15. Jolien Storme, Annelies Cannaert, Kathleen Van Craenenbroeck, Christophe P. Stove. Molecular dissection of the human A 3 adenosine receptor coupling with β-arrestin2. Biochemical Pharmacology 2018;148:298
    https://doi.org/10.1016/j.bcp.2018.01.008
  16. Xin Ma, Yunfang Xiong, Leo Lee. Application of Nanoparticles for Targeting G Protein-Coupled Receptors. IJMS 2018;19:2006
    https://doi.org/10.3390/ijms19072006
  17. Anneleen Van Hout, Alex Klarenbeek, Vladimir Bobkov, Jordi Doijen, Marta Arimont, Chunxia Zhao, Raimond Heukers, Rebecca Rimkunas, Chris de Graaf, Theo Verrips, Bas van der Woning, Hans de Haard, Joseph B. Rucker, Kurt Vermeire, Tracy Handel, Tom Van Loy, Martine J. Smit, Dominique Schols. CXCR4-targeting nanobodies differentially inhibit CXCR4 function and HIV entry. Biochemical Pharmacology 2018;158:402
    https://doi.org/10.1016/j.bcp.2018.10.015
  18. Abraham Madariaga-Mazón, Andrés F. Marmolejo-Valencia, Yangmei Li, Lawrence Toll, Richard A. Houghten, Karina Martinez-Mayorga. Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?. Drug Discovery Today 2017;22:1719
    https://doi.org/10.1016/j.drudis.2017.07.002
  19. Kyeong-Man Kim. Conceptual Progress for the Improvements in the Selectivity and Efficacy of G Protein-Coupled Receptor Therapeutics: An Overview. Biomolecules & Therapeutics 2017;25:1
    https://doi.org/10.4062/biomolther.2016.262
  20. Leif Hertz, Ye Chen. Glycogenolysis, an Astrocyte-Specific Reaction, is Essential for Both Astrocytic and Neuronal Activities Involved in Learning. Neuroscience 2018;370:27
    https://doi.org/10.1016/j.neuroscience.2017.06.025
  21. Thomas M. Tzschentke, Babette Y. Kögel, Stefanie Frosch, Klaus Linz. Limited potential of cebranopadol to produce opioid-type physical dependence in rodents. Addiction Biology 2018;23:1010
    https://doi.org/10.1111/adb.12550
  22. Hidetoshi Komatsu, Mamoru Fukuchi, Yugo Habata. Potential Utility of Biased GPCR Signaling for Treatment of Psychiatric Disorders. IJMS 2019;20:3207
    https://doi.org/10.3390/ijms20133207
  23. Jeong Hyun Lee, Ho Won Seo, Jae Yong Ryu, Chae Jo Lim, Kyu Yang Yi, Kwang-Seok Oh, Byung Ho Lee. KR-39038, a Novel GRK5 Inhibitor, Attenuates Cardiac Hypertrophy and Improves Cardiac Function in Heart Failure. Biomolecules & Therapeutics 2020;28:482
    https://doi.org/10.4062/biomolther.2020.129
  24. Jialei Zhu, Ting Sun, Jing Zhang, Yang Liu, Dongshuo Wang, Hong Zhu, Hang Yao, Jianhua Ding, Gang Hu, Ming Lu. Drd2 biased agonist prevents neurodegeneration against NLRP3 inflammasome in Parkinson’s disease model via a β-arrestin2-biased mechanism. Brain, Behavior, and Immunity 2020
    https://doi.org/10.1016/j.bbi.2020.08.025
  25. Liang Tan, Wenzhong Yan, John D. McCorvy, Jianjun Cheng. Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure–Functional Selectivity Relationships (SFSRs) and Therapeutic Potential. J. Med. Chem. 2018;61:9841
    https://doi.org/10.1021/acs.jmedchem.8b00435
  26. Xiaofei E, Paul Meraner, Ping Lu, Jill M. Perreira, Aaron M. Aker, William M. McDougall, Ronghua Zhuge, Gary C. Chan, Rachel M. Gerstein, Patrizia Caposio, Andrew D. Yurochko, Abraham L. Brass, Timothy F. Kowalik. OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism. Proc Natl Acad Sci USA 2019;116:7043
    https://doi.org/10.1073/pnas.1814850116
  27. Ken Howick, Barbara Chruscicka, Daniela Felice, Valerie T. Ramirez, Lucas van Leuven, Claudio Pietra, John F. Cryan, Brendan T. Griffin, Harriët Schellekens. Behavioural characterization of ghrelin ligands, anamorelin and HM01: Appetite and reward-motivated effects in rodents. Neuropharmacology 2020;168:108011
    https://doi.org/10.1016/j.neuropharm.2020.108011
  28. Jolien Storme, Dilip K. Tosh, Zhan-Guo Gao, Kenneth A. Jacobson, Christophe P. Stove. Probing structure-activity relationship in β-arrestin2 recruitment of diversely substituted adenosine derivatives. Biochemical Pharmacology 2018;158:103
    https://doi.org/10.1016/j.bcp.2018.10.003
  29. Supachoke Mangmool, Warisara Parichatikanond, Hitoshi Kurose. Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling. Front. Pharmacol. 2018;9
    https://doi.org/10.3389/fphar.2018.01336
  30. Terry Kenakin, Eric L. Barker. Biased Receptor Signaling in Drug Discovery. Pharmacol Rev 2019;71:267
    https://doi.org/10.1124/pr.118.016790
  31. Thomas M. Tzschentke, Klaus Linz, Thomas Koch, Thomas Christoph. The Nociceptin/Orphanin FQ Peptide Receptor. 2019.
    https://doi.org/10.1007/164_2019_206
  32. Yusuke Shintani, Atsuko Hayata-Takano, Keita Moriguchi, Takanobu Nakazawa, Yukio Ago, Atsushi Kasai, Kaoru Seiriki, Norihito Shintani, Hitoshi Hashimoto, Arun Shukla. β-Arrestin1 and 2 differentially regulate PACAP-induced PAC1 receptor signaling and trafficking. PLoS ONE 2018;13:e0196946
    https://doi.org/10.1371/journal.pone.0196946
  33. Teja Devarakonda, Fadi N. Salloum. Heart Disease and Relaxin: New Actions for an Old Hormone. Trends in Endocrinology & Metabolism 2018;29:338
    https://doi.org/10.1016/j.tem.2018.02.008
  34. Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, Jia Zhou. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. J. Med. Chem. 2019;62:88
    https://doi.org/10.1021/acs.jmedchem.8b00875
  35. Jingwei Bian, Suli Zhang, Ming Yi, Mingming Yue, Huirong Liu. The mechanisms behind decreased internalization of angiotensin II type 1 receptor. Vascular Pharmacology 2018;103-105:1
    https://doi.org/10.1016/j.vph.2018.01.008
  36. Guido Iaccarino, Daniela Sorriento. Encyclopedia of Endocrine Diseases. 2018.
    https://doi.org/10.1016/B978-0-12-801238-3.95888-4
  37. Kamila Szymańska, Joanna Kałafut, Alicja Przybyszewska, Beata Paziewska, Grzegorz Adamczuk, Michał Kiełbus, Adolfo Rivero-Müller. FSHR Trans-Activation and Oligomerization. Front. Endocrinol. 2018;9
    https://doi.org/10.3389/fendo.2018.00760
  38. Mohammad Golam Sabbir, Paul Fernyhough. Muscarinic receptor antagonists activate ERK-CREB signaling to augment neurite outgrowth of adult sensory neurons. Neuropharmacology 2018;143:268
    https://doi.org/10.1016/j.neuropharm.2018.09.020
  39. Joanna Sniecikowska, Monika Gluch-Lutwin, Adam Bucki, Anna Więckowska, Agata Siwek, Magdalena Jastrzebska-Wiesek, Anna Partyka, Daria Wilczyńska, Karolina Pytka, Gniewomir Latacz, Katarzyna Przejczowska-Pomierny, Elżbieta Wyska, Anna Wesołowska, Maciej Pawłowski, Adrian Newman-Tancredi, Marcin Kolaczkowski. Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT1A Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile. J. Med. Chem. 2020
    https://doi.org/10.1021/acs.jmedchem.0c00814
  40. Valerie T. Ramirez, Wesley E. P. A. Van Oeffelen, Cristina Torres-Fuentes, Barbara Chruścicka, Clementine Druelle, Anna V. Golubeva, Marcel Van De Wouw, Timothy G. Dinan, John F. Cryan, Harriët Schellekens. Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists. FASEB j. 2019;33:518
    https://doi.org/10.1096/fj.201800655R
  41. Pooja S. Sridhar, Daria Trofimova, Rajagopal Subramaniam, Dianevys González-Peña Fundora, Nora A. Foroud, John S. Allingham, Michele C. Loewen. Ste2 receptor-mediated chemotropism of Fusarium graminearum contributes to its pathogenicity against wheat. Sci Rep 2020;10
    https://doi.org/10.1038/s41598-020-67597-z
  42. Cristina Torres-Fuentes, Elena Pastor-Cavada, Rafael Cano, Dalia Kandil, Rachel Shanahan, Rocio Juan, Hamdy Shaban, Gerard McGlacken, Harriët Schellekens. Quinolones Modulate Ghrelin Receptor Signaling: Potential for a Novel Small Molecule Scaffold in the Treatment of Cachexia. IJMS 2018;19:1605
    https://doi.org/10.3390/ijms19061605
  43. Shaherin Basith, Minghua Cui, Stephani J. Y. Macalino, Jongmi Park, Nina A. B. Clavio, Soosung Kang, Sun Choi. Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design. Front. Pharmacol. 2018;9
    https://doi.org/10.3389/fphar.2018.00128
  44. Mohammed Nooraldeen Mahmod Al-Qattan, Mohd Nizam Mordi. Molecular Basis of Modulating Adenosine Receptors Activities. CPD 2019;25:817
    https://doi.org/10.2174/1381612825666190304122624
  45. Yann Chalopin, Francesco Piazza, Svitlana Mayboroda, Claude Weisbuch, Marcel Filoche. Universality of fold-encoded localized vibrations in enzymes. Sci Rep 2019;9
    https://doi.org/10.1038/s41598-019-48905-8
  46. Hideaki Kanki, Tsutomu Sasaki, Shigenobu Matsumura, Satoru Yokawa, Toshiro Yukami, Munehisa Shimamura, Manabu Sakaguchi, Tadahide Furuno, Takahiro Suzuki, Hideki Mochizuki. β-arrestin-2 in PAR-1-biased signaling has a crucial role in endothelial function via PDGF-β in stroke. Cell Death Dis 2019;10
    https://doi.org/10.1038/s41419-019-1375-x
  47. Ichio Shimada, Takumi Ueda, Yutaka Kofuku, Matthew T. Eddy, Kurt Wüthrich. GPCR drug discovery: integrating solution NMR data with crystal and cryo-EM structures. Nat Rev Drug Discov 2019;18:59
    https://doi.org/10.1038/nrd.2018.180
  48. Chayma El Khamlichi, Flora Reverchon-Assadi, Nadège Hervouet-Coste, Lauren Blot, Eric Reiter, Séverine Morisset-Lopez. Bioluminescence Resonance Energy Transfer as a Method to Study Protein-Protein Interactions: Application to G Protein Coupled Receptor Biology. Molecules 2019;24:537
    https://doi.org/10.3390/molecules24030537